Bolton Securities’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$321 Sell
25
-717
-97% -$5.84K ﹤0.01% 2211
2026
Q2
$7.35K Sell
742
-742
-50% -$6.2K ﹤0.01% 1874
2026
Q1
$9.1K Hold
1,484
– – ﹤0.01% 1643
2025
Q4
$12.3K Hold
1,484
– – ﹤0.01% 1543
2025
Q3
$21.6K Hold
1,484
– – ﹤0.01% 1360
2025
Q2
$16.7K Hold
1,484
– – ﹤0.01% 1368
2025
Q1
$8.46K Hold
1,484
– – ﹤0.01% 1470

Other funds holding DNA

Bolton Securities's DNA Position: Q3 2026 in Review

Bolton Securities reduced its Ginkgo Bioworks (DNA) stake by 97% in Q3 2026, selling an estimated $5.84K and leaving 25 shares worth $321. The position accounts for ﹤0.01% of the portfolio, ranked #2211.

Bolton Securities first reported a position in DNA in Q1 2025 and has held it in 7 quarters since. The position peaked at $21.6K in Q3 2025. 185 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

  • Bolton Securities held 25 shares of Ginkgo Bioworks worth $321 as of Q3 2026.
  • Bolton Securities sold 717 Ginkgo Bioworks shares in Q3 2026, an estimated $5.84K.
  • Ginkgo Bioworks made up ﹤0.01% of Bolton Securities's portfolio in Q3 2026, its #2211 holding.
  • Bolton Securities first reported a position in Ginkgo Bioworks in Q1 2025 and has held it in 7 quarters since.
  • Bolton Securities's Ginkgo Bioworks position peaked at $21.6K in Q3 2025.
  • 185 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on Bolton Securities's 13F filing for Q3 2026, filed 12 Nov 2026.